Selected article for: "IgM IgG antibody and International license"
Author: Emily R Adams; Rekha Anand; Monique I Andersson; Kathryn Auckland; J Kenneth Baillie; Eleanor Barnes; John Bell; Tamsin Berry; Sagida Bibi; Miles Carroll; Senthil Chinnakannan; Elizabeth Clutterbuck; Richard J Cornall; Derrick W Crook; Thushan De Silva; Wanwisa Dejnirattisai; Kate E Dingle; Christina Dold; David W Eyre; Helen Farmer; Sarah J Hoosdally; Alistair Hunter; Katie Jeffrey; Paul Klenerman; Julian Knight; Clarice Knowles; Andrew J Kwok; Ullrich Leuschner; Chang Liu; Cesar Lopez-Camacho; Philippa C Matthews; Hannah McGivern; Alexander J Mentzer; Jonathan Milton; Juthathip Mongkolsapaya; Shona C Moore; Marta S Oliveira; Fiona Pereira; Timothy Peto; Rutger J Ploeg; Andrew Pollard; Tessa Prince; David J Roberts; Justine K Rudkin; Gavin R Screaton; Malcolm G Semple; Donal T Skelly; Elliot Nathan Smith; Julie Staves; David Stuart; Piyada Supasa; Tomas Surik; Pat Tsang; Lance Turtle; A Sarah Walker; Beibei Wang; Charlotte Washington; Nicholas Watkins; James Whitehouse; Sally Beer; Robert Levin; Alexis Espinosa; Dominique Georgiou; Jose Carlos Martinez Garrido; Hannah Thraves; Elena Perez Lopez; Maria del Rocio Fernandez Mendoza; Alberto Jose Sobrino Diaz; Veronica Sanchez
Title: Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays
  • Document date: 2020_4_20
    • ID: 5trox1i5_11
    Snippet: We tested 90 samples using ELISA to quantify IgM and IgG antibody in plasma designated SARS-CoV-2 negative (n=50) and positive (n=40). All positive samples were included and an unstratified random sample of negative plasma from healthy blood donors (n=23) and organ donors (n=27). We tested the nine different LFIA devices using between 39-165 individual . CC-BY 4.0 International license It is made available under a is the author/funder, who has gr.....
    Document: We tested 90 samples using ELISA to quantify IgM and IgG antibody in plasma designated SARS-CoV-2 negative (n=50) and positive (n=40). All positive samples were included and an unstratified random sample of negative plasma from healthy blood donors (n=23) and organ donors (n=27). We tested the nine different LFIA devices using between 39-165 individual . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • blood donor and healthy blood donor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • blood donor and IgG antibody: 1, 2, 3, 4, 5, 6, 7
    • blood donor and international license: 1
    • blood donor and negative plasma: 1, 2, 3
    • blood donor and organ donor: 1, 2, 3
    • blood donor and plasma IgG antibody: 1, 2
    • blood donor and positive sample: 1, 2, 3, 4, 5
    • cc international license and IgG antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • cc international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc international license and negative plasma: 1
    • cc international license and plasma IgG antibody: 1
    • cc international license and positive sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cc international license and random sample: 1, 2, 3, 4, 5
    • healthy blood donor and IgG antibody: 1
    • IgG antibody and negative plasma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • IgG antibody and organ donor: 1
    • IgG antibody and plasma IgG antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • IgG antibody and positive sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • IgG antibody and random sample: 1, 2